ALLONK

Cells for medical or clinical use; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of lymphoma; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer; Therapeutic pharmaceutical for the treatment of breast cancer; Therapeutic pharmaceutical for the treatment of lymphoma; Therapeutic pharmaceutical for the treatment of tumors; Tumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Biological preparations for the treatment of breast cancer; Biological preparations for the treatment of lymphoma; Biological preparations for the treatment of tumors; Living cells for medical use; Pharmaceutical products for the treatment of cancer